ask="0.5800"
ask_size="3800"
average_daily_volume="564773"
bid="0.3900"
bid_size="2000"
book_value="0.8130"
change="+0.0485"
change_from_200_day_moving_average="0.0548"
change_from_50_day_moving_average="0.0427"
change_from_52_week_high="-0.8214"
change_From_52_week_low="0.2675"
change_in_percent="+8.8182%"
close="0.5985"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.5350"
ebitda="-17.93M"
eps_estimate_current_year="-0.7800"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.5700"
ex_dividend_date="N/A"
float_shares="29627000"
high="0.6100"
high_52_weeks="1.4199"
last_trade_date="2/7/2017"
last_trade_price="0.5985"
last_trade_size="807"
last_trade_time="4:00pm"
low="0.5400"
low_52_weeks="0.3310"
market_capitalization="17.97M"
moving_average_200_day="0.5437"
moving_average_50_day="0.5558"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.9000"
open="0.5718"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+10.0744%"
percent_change_from_50_day_moving_average="+7.6908%"
percent_change_from_52_week_high="-57.8491%"
percent_change_from_52_week_low="+80.8157%"
previous_close="0.5500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.6765"
price_per_sales="1.4894"
revenue="11.09M"
shares_outstanding="30020000"
short_ratio="0.8300"
stock_exchange="NCM"
symbol="OGXI"
volume="677408"
weeks_range_52="0.3310 - 1.4199"
